Search results for: Roche
Filter search results
A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance
19 May 2023
…is the time for policymakers to act. This contract research report, ‘A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance’, was commissioned and funded by Roche Diagnostics….
Daniel Ollendorf
3 February 2023
…from Boston University, and a Bachelor of Arts from the University of Rochester. He has authored over 60 peer-reviewed articles in major journals, and has presented widely on HTA and…
OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare
15 June 2020
…more information, please contact: Mikel Berdud This study was commissioned and funded by Hoffmann La Roche. Berdud M., Ferraro J., Towse A. A theory on ICER pricing and optimal level…
Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology
3 July 2018
…Manchester University NHS Foundation Trusts. The study was funded by Roche Products Ltd. Download the full report here. For more information about OHE’s research on this topic, contact…
Recently Published: MCDA to Elicit Stakeholders’ Preferences: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma
20 December 2016
…these to assess the value of obinutuzumab for rituximab-refractory indolent non-Hodgkin lymphoma (iNHL). The study was funded by Roche S.P.A. This is the first time that a multi criteria decision…
Spotlight on OHE: Adaptive Pathways, Economic Evaluation, Stated Preferences and Life-cycle Price Modelling
5 November 2014
…perspective was presented by Dr Jens Grueger; Hoffmann-La Roche, Switzerland. Adaptive licensing cirs_akt_oct2014 from Office of Health Economics For additional information please contact Adrian Towse at OHE. Models…
ISPOR Task Force Report on Performance-Based Risk-Sharing Arrangements
28 August 2013
…Andrew Briggs, University of Glasgow; Gerard de Pouvourville, ESSEC Business School, France; Jens Grueger, F. Hoffmann-La Roche; Penny Mohr, Center for Medical Technology Policy, USA; J.L. Severens, Erasmus University Rotterdam;…
Spotlight on OHE: Understanding Value Based Pricing
12 February 2013
…health care systems and the role of patients’ groups that was organised by Roche and EGAN, the Patients’ Network for Medical Research and Health, which is an alliance of European patients’…
OHE Conference on Drug Development in 2022: Update
18 July 2012
…The Wharton School, University of Pennsylvania Dr Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency Dr Jens Grueger, Head, Global Health Economics and Pricing, Roche Pharmaceuticals Dr Hannah Kettler, Senior…